Are health technology assessments of pharmacogenetic tests feasible? A case study ofCYP2D6testing in the treatment of breast cancer with tamoxifen
about
Are health technology assessments of pharmacogenetic tests feasible? A case study ofCYP2D6testing in the treatment of breast cancer with tamoxifen
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2013
@uk
name
Are health technology assessme ...... f breast cancer with tamoxifen
@en
Are health technology assessme ...... f breast cancer with tamoxifen
@nl
type
label
Are health technology assessme ...... f breast cancer with tamoxifen
@en
Are health technology assessme ...... f breast cancer with tamoxifen
@nl
prefLabel
Are health technology assessme ...... f breast cancer with tamoxifen
@en
Are health technology assessme ...... f breast cancer with tamoxifen
@nl
P2093
P2860
P50
P356
P1476
Are health technology assessme ...... f breast cancer with tamoxifen
@en
P2093
Ana Fernández Santander
Angela Boland
Carlos Martin Saborido
James Oyee
Nigel Fleeman
Rumona Dickson
P2860
P304
P356
10.2217/PME.13.60
P407
P577
2013-08-01T00:00:00Z